Showing 4 results for Hejazi
Dr N Valizadeh, Dr F Farrokhi, Mr V Alinejad, Dr Sm Said Mardani, Dr N Valizadeh, Dr S Hejazi, Dr M Noroozi,
Volume 4, Issue 2 (6-2014)
Abstract
Background
Patients with thalassemia major and intermedia are
susceptible to osteopenia and osteoporosis. The
mechanism of osteoporosis in these patients is
multifactorial. Transfusion related iron overload in
endocrine organs leads to impaired growth hormone
secretion, diabetes mellitus, hypothyroidism,
hypoparathyroidism, lack of sex steroids and vitamin
D deficiency that contribute to impairment in
achieving an adequate bone mass .The aim of this
study was assessment of frequency of bone loss in
patients with thalassemia major and intermedia in
Urmia City of West Azerbaijan, Iran
Materials and Methods
In this cross sectional descriptive study,10 patients
(lower than 18 y/o)with transfusion dependent
thalassemia attending to Motahari and Emam
Khomeini hospitals in Urmia city of Iran were
enrolled and scanned for Bone Mineral Density
(BMD) starting at around 10 years old.
Results
Tenatients (6 male and 4 female) with transfusion
dependent thalassemia (β-thalassemia major and
intermedia) aged 13to 17 years in Urmia city of Iran
were enrolled. Mean age of patients was
15.1±.37year old. Among them, 8 patients (80%)had
low BMD and2 of them (20%) had normal BMD in
lumbar spine. Only 30% of patients had low BMD in
the neck of femur.
Conclusion
We should perform annual BMD in patients with
thalassemia major and intermedia and hemoglobin H
disease in age of higher than 8 year old and treat low
BMD with administration of bisphosphonate, calcium
and vitamin D supplements. Medical consultation
with a rheumatologist and /or an endocrinologist
should be performed in these patients. Changing
lifestyle with mild daily exercise, adequate calcium
containing foods, avoiding heavy activities, stop
smoking, iron chelation therapy in adequate dosage,
early diagnosis and treatment of endocrine
insufficiency and regular blood transfusions can help
to achieve an optimal bone density in these patients.
Dr N Valizadeh, Dr M Noroozi, Dr S Hejazi, Dr Sh Nateghi, Dr A Hashemi,
Volume 5, Issue 3 (8-2015)
Abstract
Abstract
Background
Thalassemia patients that are conventionally treated by a regular transfusion regimen are exposed to blood born viral infections.The aim of this study was to investigate the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) , and human Immunodeficiency virus(HIV) among all multitransfused thalassemia patients in west north of Iran.
Material and methods
A retrospective study was conducted in February 2014, on 32 patients in Urmia, suffering from transfusion dependent thalassemia were admitted to Motahari and Emam Khomeini hospitals. Patients’ medical records were studied for HBs antigen and seropositivity for HCV, and HIV antibodies.
Results
Out of 32transfusion dependent thalassemia patients aged between 5-17years, 18 (56.25%) and14 (43.75%) were male and female, respectively. All of them were found seronegative for HBs antigen, HCV, and HIV antibodies.
Conclusion
It seems that screening of blood products is efficient in Urmia , capital of West Azarbaijan, Iran for prevention of blood born viral infections.
Ms N Valizadeh, Mr V Alinejad, Mr S Hejazi, Mr M Noroozi, Mr A Hashemi, Mr B Rahimi, Mr Sh Nateghi,
Volume 5, Issue 4 (12-2015)
Abstract
Abstract
Background
Iron overload is the main transfusion related side effects in patients with transfusion dependent hemoglobinopathies. Severe iron deposition in tissues leads to organ dysfunction. Many organs can be affected such as heart, liver, and endocrine organs. Cardiac failure and liver fibrosis are the consequent of Iron overload in transfusion dependent hemoglobinopathy. Magnetic Resonance Imaging (MRI) is a safe, noninvasive, and accurate method for the assessment of iron deposition in different tissues. This study assessed iron levels in liver and heart of the patients with transfusion dependent hemoglobinopathies.
Materials and Methods
The studied population consisted of 12 patients (7 male and 5 female) with transfusion dependent hemoglobinopathies, aged between 10-18 years old. Then, Cardiac and liver T2*-weighted magnetic resonance imaging (MRI) were obtained.
Results
In current study, 1patient (8.33%) had severe, 2 patients (16.66%) had moderate and 2(16.66%) had mild cardiac iron deposition. Out of 12 patients, 1 had severe iron deposition in liver (8.33%), 5(41.66%) and 4(33.33%) had moderate and mild hepatic iron deposition, respectively. Differences between Hepatic and cardiac iron levels were not significant between males and females (p>0.05).
Conclusion
Since cardiac and liver iron levels were higher than normal in most of the study group, checking ferritin level and liver function test and also echocardiography in shorter intervals (each 3 months) in involved group is suggested instead of checking routinely in 6 month intervals in patients with transfusion dependent hemoglobinopathies.
Dr Sh Gheibi, Dr M Noroozi, Dr S Hejazi, Dr M Karamyyar, Dr H Farrokh-Eslamlou,
Volume 6, Issue 1 (3-2016)
Abstract
Abstract
Background
Iron-deficiency anemia is a widespread public health problem with major consequences for human health especially, children. However, in a fraction of patients an underlying cause is never found during routine investigation. Recent studies have
suggested an association between Helicobacter pylori (H. Pylori) infection and iron-deficiency anemia.
Case presentation
Here is reported four school aged children (two male, two female) with refractory severe iron-deficiency anemia associated
H. Pylori gastritis. Mean age of the patients was 13.62 years old and they were admitted with chief complaints of abdominal, chest pain weakness, headache and respiratory distress. Mean hemoglobin level in patients was 6.2 g/dl with persistence to iron therapy. After the diagnosis and therapy of H. pylori infection, clinical complaints, hemoglobin level and iron profiles were being normal and they gained weight.
Conclusion
This study suggests screening of H. pylori infection and appropriate treatment in any case of refractory moderate to severe irondeficiency anemia, especially with clinical manifestations of gastrointestinal tract in children.